NCT00008307 2014-01-06Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersNational Cancer Institute (NCI)Phase 2 Unknown52 enrolled
NCT00907036 2013-08-02Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin LymphomaNational Cancer Institute (NCI)Phase 2 Unknown49 enrolled
NCT00908180 2013-08-02Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Phase 2 Unknown47 enrolled
NCT00740467 2010-01-28Stem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersNational Cancer Institute (NCI)Phase 2 Unknown50 enrolled